BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15137175)

  • 1. Activity of cholinesterases in human whole blood measured with acetylthiocholine as substrate and ethopropazine as selective inhibitor of plasma butyrylcholinesterase.
    Reiner E; Bosak A; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2004 Apr; 55(1):1-4. PubMed ID: 15137175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
    Tunek A; Svensson LA
    Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of protocols for measuring activities of human blood cholinesterases by the Ellman method.
    Reiner E; Sinko G; Skrinjarić-Spoljar M; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2000 Mar; 51(1):13-8. PubMed ID: 11059068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods used for the determination of cholinesterase activity in whole blood.
    Naik RS; Doctor BP; Saxena A
    Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cetyltrimethylammonium on the human blood cholinesterases activity].
    Kuznetsova LP; Samokish VA; Sochilina EE
    Ukr Biokhim Zh (1999); 2011; 83(2):29-35. PubMed ID: 21851044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
    Thomsen T; Kewitz H; Pleul O
    J Clin Chem Clin Biochem; 1988 Jul; 26(7):469-75. PubMed ID: 3065439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
    Tvarijonaviciute A; Ceron JJ; Tecles F
    Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.
    Golicnik M; Sinko G; Simeon-Rudolf V; Grubic Z; Stojan J
    Arch Biochem Biophys; 2002 Feb; 398(1):23-31. PubMed ID: 11811945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition by various alkaloids of acetylcholinesterase and butyrylcholinesterase from human blood].
    Kuznetsova LP; Nikol'skaia EB; Sochilina EE; Faddeeva MD
    Zh Evol Biokhim Fiziol; 2002; 38(1):28-31. PubMed ID: 11966199
    [No Abstract]   [Full Text] [Related]  

  • 11. A ratiometric fluorescence probe based on carbon dots for discriminative and highly sensitive detection of acetylcholinesterase and butyrylcholinesterase in human whole blood.
    Xu X; Cen Y; Xu G; Wei F; Shi M; Hu Q
    Biosens Bioelectron; 2019 Apr; 131():232-236. PubMed ID: 30849722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid.
    Jayanthi LD; Balasubramanian N; Balasubramanian AS
    Clin Chim Acta; 1992 Feb; 205(3):157-66. PubMed ID: 1349516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenyl valerate esterase activity of human butyrylcholinesterase.
    Mangas I; Vilanova E; Estévez J
    Arch Toxicol; 2017 Oct; 91(10):3295-3305. PubMed ID: 28299395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved determination of acetylcholinesterase activity in human whole blood.
    Worek F; Mast U; Kiderlen D; Diepold C; Eyer P
    Clin Chim Acta; 1999 Oct; 288(1-2):73-90. PubMed ID: 10529460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase reactivation: in vitro studies.
    Ganendran A; Balabaskaran S
    Anaesth Intensive Care; 1975 Feb; 3(1):60-1. PubMed ID: 1130650
    [No Abstract]   [Full Text] [Related]  

  • 16. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
    Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
    Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of pseudocholinesterase in Torpedo marmorata tissues: comparative study of the catalytic and molecular properties of this enzyme with acetylcholinesterase.
    Toutant JP; Massoulié J; Bon S
    J Neurochem; 1985 Feb; 44(2):580-92. PubMed ID: 2578181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to determining cholinesterase activities in samples of whole blood.
    Augustinsson KB; Eriksson H; Faijersson Y
    Clin Chim Acta; 1978 Oct; 89(2):239-52. PubMed ID: 709874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of cholinesterases by aziridinium derivatives of polymethylene bischloroethylamines].
    Volkova RI; Kochetova LM
    Bioorg Khim; 1983 Jul; 9(7):926-35. PubMed ID: 6679787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of interaction with acetylcholinesterase and butyrylcholinesterase of choline analogs based on ephedrine and pseudoephedrine].
    Dalimov DN; Vaĭzburg GM; Abdullaeva LK; Abduvakhabov AA; Sadykov AS
    Dokl Akad Nauk SSSR; 1986; 289(1):227-30. PubMed ID: 3732039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.